NCT04203186View on ClinicalTrials.gov

A Clinical Trial to Evaluate Plasmodium Falciparum 7G8 and NF54 Challenge Strains (PfSPZ) in a Head-to-head Comparative Study - (ECG-CHMI)

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 31, 2020

Primary Completion Date

June 30, 2021

Study Completion Date

September 30, 2021

Conditions
Plasmodium Falciparum
Interventions
DRUG

atovaquone-proguanil

Malaria standard treatment regimen

Sponsors
All Listed Sponsors
collaborator

Naval Medical Research Center

FED

lead

U.S. Army Medical Research and Development Command

FED

NCT04203186 - A Clinical Trial to Evaluate Plasmodium Falciparum 7G8 and NF54 Challenge Strains (PfSPZ) in a Head-to-head Comparative Study - (ECG-CHMI) | Biotech Hunter | Biotech Hunter